glp-1 sglt2 Perspectives in weight control in diabetes – inhibitors and GLP-1–glucagon dual agonism SGLT-2 Inhibitors and GLP-1 Agonists:
Description
doi: 10.3390/cancers15020485
Because sublingual bioavailability is lower than injection bioavailability, the actual milligram dose in the drops is higher than the equivalent injectable dose
doi: 10.1007/s00125-005-0128-9 49 NishiHHigashiharaTInagiR
The mechanism makes physiological sense
